Strategies for physician education in therapeutic drug monitoring.
暂无分享,去创建一个
D W Bates | D. Bates | S. Soldin | P M Rainey | S J Soldin | J N Micelli | P. Rainey | J. N. Micelli
[1] P. Lietman,et al. Serum vancomycin concentrations: reappraisal of their clinical value. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J H Harrison,et al. Identification of patients for pharmacologic review by computer analysis of clinical laboratory drug concentration data. , 1995, American journal of clinical pathology.
[3] D W Bates,et al. Evaluating the appropriateness of digoxin level monitoring. , 1999, Archives of internal medicine.
[4] Gordon H. Guyatt,et al. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. , 1993, JAMA.
[5] D W Bates,et al. Appropriateness of antiepileptic drug level monitoring. , 1995, JAMA.
[6] S B Soumerai,et al. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. , 1984, The Milbank Memorial Fund quarterly. Health and society.
[7] G. Guyatt,et al. Users' guides to the medical literature. , 1993, JAMA.
[8] Jonathan M. Teich,et al. Potential identifiability and preventability of adverse events using information systems. , 1994, Journal of the American Medical Informatics Association : JAMIA.
[9] F. Bochner,et al. Therapeutic Drug Monitoring and Patient Outcome , 1994, Clinical pharmacokinetics.
[10] L. Ried,et al. Meta-analysis of research on the effect of clinical pharmacokinetics services on therapeutic drug monitoring. , 1989, American journal of hospital pharmacy.
[11] M. Enkin,et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. , 1989, The New England journal of medicine.
[12] J M Teich,et al. Computerized physician order entry and quality of care. , 1994, Quality management in health care.
[13] Thomas Lee,et al. Critical Pathways as a Strategy for Improving Care: Problems and Potential , 1995, Annals of Internal Medicine.
[14] William W. Stead,et al. Review: Computer-based Physician Order Entry: The State of the Art , 1994, J. Am. Medical Informatics Assoc..
[15] M. Raebel,et al. Vancomycin Therapeutic Drug Monitoring: Is it Necessary? , 1993, The Annals of pharmacotherapy.
[16] N. Saunders. Why monitor peak vancomycin concentrations? , 1994, The Lancet.
[17] G. Koren,et al. Organization and efficacy of a therapeutic drug monitoring consultation service in a pediatric hospital. , 1985, Therapeutic drug monitoring.
[18] D. Wing,et al. Impact of a therapeutic drug monitoring program for digoxin. , 1987, Archives of internal medicine.
[19] C. McDonald,et al. Physician inpatient order writing on microcomputer workstations. Effects on resource utilization. , 1993, JAMA.
[20] J. Lomas,et al. From evidence to practice in the United States, the United Kingdom, and Canada. , 1993, The Milbank quarterly.